Discipline
News, research analysis and evidence-based explanation. 20 stories in this section.
Scientists have developed an injectable gel that converts other brain cells into neurons, a breakthrough that could lead to new treatments for Alzheimer’s and other neurodegenerative diseases.
Researchers have found that a protein called AHR acts as a brake on the nervous system's ability to repair damaged connections. Blocking AHR helped injured nerve fibers regrow and improved …
A randomized trial presented at the 2026 European Society of Cardiology Congress found that combining direct oral anticoagulants with potent P2Y12 inhibitors in atrial fibrillation and acute coronary syndrome patients …
Researchers have discovered a brain-based mechanism that acts like a brake to calm an overactive pain circuit in mice, potentially opening the door to new chronic pain treatments that avoid …
Researchers have developed nanoparticles that light up glioblastoma cells during surgery and destroy microscopic remnants afterward, preventing recurrence in mice with 100% survival at 60 days. Human trials are pending.
Modern medicine excels at prescribing drugs but offers little support for patients who need to stop them. Clinical trials rarely study long-term use or discontinuation, leaving doctors without evidence-based guidance …
A nanoparticle-based treatment improved memory and learning in mice with Alzheimer’s disease by converting star-shaped brain cells into functioning neurons, reducing amyloid-beta levels and brain inflammation.
The US Food and Drug Administration has approved daraxonrasib, a first-of-a-kind oral drug that blocks a mutated protein driving tumor growth in more than 90% of pancreatic cancer cases, offering …
One U.S. lot of Vitruvias Thyroid Tablets, USP 30 mg is being recalled after testing raised concern that the medicine may deliver too much thyroid hormone.
A man with urinary incontinence attempted to stop the leaking by sealing his urethra with cyanoacrylate glue, a case report reveals. The unusual self-treatment led to severe complications requiring surgery, …
A large clinical trial suggests that a personalized mRNA vaccine combined with the immunotherapy drug Keytruda may help prevent melanoma from returning after surgery.
Researchers have identified a decades-old chemical compound as a promising new candidate for treating obesity and related metabolic diseases, reviving interest in a drug originally developed for other purposes.
Researchers at King's College London identified a new therapeutic mechanism for heart failure with preserved ejection fraction (HFpEF), a condition affecting nearly half of all heart failure patients. The natural …
A long-nosed fur seal found dead in South Australia has become the first mammal on the Australian mainland confirmed to have died from the H5 bird flu strain, signaling a …
Scientists studying Argentine hemorrhagic fever and other rare pathogens in South America are uncovering how climate change and land use may drive the next pandemic, using local vaccines and surveillance …
A University of Texas study suggests that COVID-19 infection could reactivate latent viruses such as Epstein-Barr and herpesviruses, even in individuals without severe symptoms, potentially explaining long-term complications.
Medical groups want the clock changes to end too, but they favor permanent standard time because morning light aligns more closely with human circadian biology.
Hunter Biden’s new description of his father’s pain has renewed interest in a diagnosis announced in 2025. Here is what the public record and National Cancer Institute guidance actually establish.
A new perspective paper published in The American Journal of Clinical Nutrition urges public health agencies to rethink how they address hypertension, calling for a broader dietary strategy that goes …
Preliminary research raises the possibility that a protein tied to Alzheimer’s disease could also serve as a biological marker for CTE, the brain condition linked to repeated head trauma in …
